Back to Results
First PageMeta Content
Cervarix / HPV vaccine / Human papillomavirus / Gardasil / Cervical cancer / Wart / AS04 / Cervical intraepithelial neoplasia / Genital wart / Papillomavirus / Medicine / Microbiology


FDA Briefing Document Vaccines & Related Biological Products Advisory Committee Meeting September 9, 2009 CervarixTM GlaxoSmithKline Biologicals
Add to Reading List

Open Document

File Size: 944,10 KB

Share Result on Facebook

Company

GlaxoSmithKline Biologicals / Glaxosmithkline plc / /

Continent

America / Asia / Europe / South America / /

Country

Taiwan / Germany / Sweden / Honduras / Norway / Colombia / France / United States / Brazil / Panama / Canada / Australia / Korea / Spain / Czech Republic / /

Event

FDA Phase / /

IndustryTerm

injection site / Prevention of cervical cancer / prevention of HPV-related disease / prevention of the following diseases / prevention of HPV infection and disease / /

MedicalCondition

hepatitis A / sexually transmitted disease / cervical cancers / HBV / cervical infection / natural infection / incident infection / genital warts / spontaneous abortions / CIN / infections / adenocarcinoma / squamous cell carcinoma / Cancer / disease / HPV / cervical cancer / Persisent infection / cervical adenocarcinoma / studies New Onset Chronic Diseases / cervical intraepithelial neoplasia / vaginal and vulvar cancer / female cancer / persistent infection / diseases / infection / invasive cervical cancer / /

MedicalTreatment

vaccination / /

Organization

World Health Organization / FDA Briefing Document Vaccines & Related Biological Products Advisory Committee / Division of Vaccines / Centers for Disease Control and Prevention / Advisory Committee on Immunization Practices / Human Papillomavirus / World Health Organization International Agency for Research and Cancer / FDA / American Cancer Society / Vaccines and Related Biological Products Advisory Committee / GSK VRBPAC / /

Person

Nancy Miller / /

Product

HPV-002 / VLP vaccine / AlOH3 / Cohort-1 / HPV-001 / Cervarix™ / CIN2 / HPV-008 / /

Region

North Americas / /

Technology

alpha / DLP / recombinant DNA technology / /

URL

http /

SocialTag